SEOUL, Nov. 11 (Korea Bizwire) – South Korea’s biotechnology industry output grew nearly 10 percent in 2024 from a year earlier despite persistent global trade uncertainties, industry data showed Tuesday. The country’s biotechnology industry production came to 22.92 trillion won (US$15.7 billion) last year, up from 20.87 trillion won in 2023, the Ministry of Trade, [...]
SEOUL, Oct. 21 (Korea Bizwire) – LG Chem Ltd.’s polio vaccine manufacturing facility in South Korea has received a certificate of containment from the World Health Organization (WHO), the first such recognition in Asia, the disease control agency said Tuesday. The facility was among only three in the world to earn the WHO certification, following [...]
SEOUL, Oct. 17 (Korea Bizwire) — South Korean pharmaceutical companies are intensifying efforts to develop combination drugs — single pills that treat multiple conditions — as patient demand for convenience and cost efficiency rises. Combination drugs contain two or more active ingredients, allowing patients to reduce pill intake and treatment expenses. According to industry sources [...]
SEOUL, Oct. 10 (Korea Bizwire) — While much of the world races to unlock the economic and therapeutic potential of medical cannabis, South Korea remains mired in outdated regulations that treat even non-psychoactive compounds as narcotics. Lawmakers and experts warn that this rigid stance is stifling domestic innovation, draining public healthcare funds, and pushing patients [...]
SEOUL, Oct. 10 (Korea Bizwire) – Celltrion Inc., a leading South Korean biopharmaceutical company, said Friday its biosimilar for eye diseases has received approval for sale in the United States. The U.S. Food and Drug Administration (FDA) has approved Eydenzelt, Celltrion’s biosimilar referencing Eylea, for the treatment of wet age-related macular degeneration and other ophthalmic [...]
SEOUL, Oct. 7 (Korea Bizwire) — South Korea’s pharmaceutical and biotech firms are racing to close out the year under mounting pressure, with looming U.S. tariffs and sluggish drug development emerging as key challenges after the Chuseok holiday. Industry sources said Monday that the most immediate concern is the “U.S. tariff risk” following President Donald [...]
SEOUL, Sept. 29 (Korea Bizwire) — South Korea’s biosimilar industry is ramping up competition at home and abroad, with companies racing to secure early approvals, expand sales networks, and leverage artificial intelligence as differentiators in a crowded market. At least six biosimilars won approvals or launches globally this month alone, underscoring the pace of expansion. Celltrion [...]
SEOUL, Sept. 22 (Korea Bizwire) — A string of hacking incidents at South Korea’s telecommunications and financial companies has prompted pharmaceutical and biotech firms to tighten their defenses, wary that breaches involving sensitive clinical data and intellectual property could trigger irreparable damage. Industry officials said this week that companies are moving quickly to reinforce security policies [...]
SEOUL, Sept. 5 (Korea Bizwire) — South Korea on Friday outlined a plan to help the biohealth industry double its exports by 2030 and join the world’s top five. Under the “K-Bio Leap Strategy” unveiled at a seminar in Songdo, west of Seoul, the government outlined new targets for the industry, which also include the [...]
SEOUL, Aug. 28 (Korea Bizwire) — Celltrion Inc., a leading South Korean biopharmaceutical company, said Thursday it will strengthen its biosimilar lineup in Vietnam to meet rising demand in the Southeast Asian country. Celltrion launched two biosimilars in Vietnam this year — Remsima, for the treatment of autoimmune diseases, in June, and Herzuma, for breast [...]